Abraham Kim, MD
Adult Reconstructive Orthopaedic Surgery · Laguna Woods, CANPI 1902123789
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 72.0% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,365, 2.9 times the $467 reported in 2019. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in CA, where the typical reported total is $9,645.
Across 51 payments — averaging $59.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Stryker$324
- Pacira Therapeutics, Inc.$203
- AbbVie$105
- Johnson & Johnson$102
- Medical Device Business Services, Inc.$38
- plus $78 from 4 others
What the payments were for
- Travel & lodging$1,14838%
- Food & beverage$1,46748%
- Education$41914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 24 | $2,184 |
| Stryker | 6 | $324 |
| Pacira Therapeutics, Inc. | 7 | $203 |
| AbbVie | 6 | $105 |
| Johnson & Johnson | 2 | $102 |
| Medical Device Business Services, Inc. | 2 | $38 |
| Boston Scientific | 1 | $26 |
| Innovation Technologies Inc | 1 | $24 |
| Illuminoss Medical, Inc. | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford$1,292
- MAKO$150
- mymobility Platform$106
How this compares
$3,034 in reported general payments places this provider in the 30th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 688 | $2,738 |
| Diclofenac Potassium | 60 | $895 |
| Oxycodone Hcl | 132 | $773 |
| Methocarbamol | 124 | $730 |
| Meloxicam | 289 | $359 |
| Ondansetron OdtOndansetron | 15 | $153 |
| Tramadol Hcl | 33 | $139 |
| Celecoxib | 11 | $95 |
| Methylprednisolone | 13 | $90 |
| Gabapentin | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Laguna Woods
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
- Derek AmanatullahStanford$828K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.